Designing products that meet community aspirations – Understanding end-user preferences for emerging HIV biomedical prevention technologies across East Africa and India
Chair
Jean-Daniel LELIEVRE, IAS, France
Moderator
Ethel MAKILA
IAVI, Kenya
Organizer
Share
The satellite will provide insights into the acceptability of various prevention products among specific vulnerable population groups across East Africa and India. It will also highlight the need to bring together different stakeholders, in addition to the end-users, early on at the time of clinical development planning. The essence of technological advancements and health system delivery lessons in the post-COVID era, which may serve as useful leads for future product planning, will be discussed, which will help guide product developers in defining the unique value proposition for upcoming prevention interventions, account for specific importance to critical product attributes and identify effective communication channels and delivery strategies. It will also help funders to direct investments in areas where they are needed. Most importantly, the session will re-emphasize the need to have community voices and user choices at the heart of product development.
09:30
4 min
Introduction
IAS, France
09:34
14 min
Injectable and implantable long-acting-PrEP - Facilitators of and barriers to uptake and adherence among adolescent girls and young women and female sex workers in Kenya and Uganda
IAVI, Kenya
09:48
14 min
Stated Choices regarding PrEP, Rectal Microbicides and HIV Vaccines among Men who have Sex with Men in India
Centre for Sexuality and Health Research and Policy (C-SHaRP), India
10:02
14 min
HIV bNAbs as Prevention Products: End-User Acceptability and Health System Feasibility in India
International AIDS Vaccine Initiative, India
IAVI, India
10:16
14 min
Multipurpose technologies - Market segmentation studies among adolescent girls and young women and female sex workers in Kenya and Uganda
BUSARA CENTER FOR BEHAVIORAL ECONOMICS, Kenya
10:30
3 min
Summary
IAVI, Kenya
10:33
25 min
Q&A
International AIDS Vaccine Initiative, India
IAVI, India
BUSARA CENTER FOR BEHAVIORAL ECONOMICS, Kenya
IAVI, Kenya
Centre for Sexuality and Health Research and Policy (C-SHaRP), India
IAS, France
IAVI, Kenya
10:58
2 min
Closing Remarks
IAS, France